Your browser doesn't support javascript.
loading
Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
Shaibu, Joseph Ojonugwa; Onwuamah, Chika K; James, Ayorinde Babatunde; Okwuraiwe, Azuka Patrick; Amoo, Olufemi Samuel; Salu, Olumuyiwa B; Ige, Fehintola A; Liboro, Gideon; Odewale, Ebenezer; Okoli, Leona Chika; Ahmed, Rahaman A; Achanya, Dominic; Adesesan, Adesegun; Amuda, Oyewunmi Abosede; Sokei, Judith; Oyefolu, Bola A O; Salako, Babatunde Lawal; Omilabu, Sunday Aremu; Audu, Rosemary Ajuma.
Affiliation
  • Shaibu JO; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Onwuamah CK; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • James AB; Biochemistry Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Okwuraiwe AP; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Amoo OS; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Salu OB; Department of Medical Microbiology and Parasitology, Centre for Human and Zoonotic Virology, College of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.
  • Ige FA; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Liboro G; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Odewale E; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Okoli LC; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Ahmed RA; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Achanya D; Department of Cell Biology and Genetics, University of Lagos, Akoka, Lagos, Nigeria.
  • Adesesan A; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Amuda OA; Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Sokei J; Centre for Tuberculosis Research, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Oyefolu BAO; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Salako BL; Department of Microbiology, Virology Research Group, Lagos State University, Ojo, Lagos, Nigeria.
  • Omilabu SA; Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Audu RA; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
PLoS One ; 16(1): e0243271, 2021.
Article in En | MEDLINE | ID: mdl-33428634
ABSTRACT
In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers' instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Country/Region as subject: Africa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Type: Article Affiliation country: Nigeria

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Country/Region as subject: Africa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Type: Article Affiliation country: Nigeria